Vertex Pharmaceuticals Inc
DUS:VX1
Vertex Pharmaceuticals Inc
DUS:VX1
Price:
416.85
EUR
0.68%
Market Closed
Market Cap:
€49.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
M
|
Mettler-Toledo International Inc
F:MTO
|
US |
|
Power Solutions International Inc
NASDAQ:PSIX
|
US |
|
G
|
Ganfeng Lithium Group Co Ltd
SWB:39EA
|
CN |
|
Telenor ASA
OTC:TELNY
|
NO |
|
5
|
5E Advanced Materials Inc
NASDAQ:FEAM
|
US |
|
Century Communities Inc
NYSE:CCS
|
US |
|
Unity Software Inc
NYSE:U
|
US |
|
N
|
Norwegian Air Shuttle ASA
OSE:NAS
|
NO |
Multiples-Based Value
The Multiples-Based Value for 
Vertex Pharmaceuticals Inc (VX1) under the Base Case is hidden
EUR.
Compared with the current market price of 416.85 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VX1 Multiples-Based Value
LOCKED
